Malachite Innovations, Inc.
OTC: VBIO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Michael R. Cavanaugh CPA,
- Employees
- 3
- Headquarters
- Los Angeles, United States
- IPO year
- 2008
- Market cap
- $2.6M
- Website
- http://www.malachiteinnovations.com
Loading VBIO…
Loading profile data…Frequently asked questions about VBIO
What does Malachite Innovations, Inc. (VBIO) do?
Vitality Biopharma, Inc. specializes in creating cannabinoid-based pharmaceuticals, primarily focusing on addressing inflammatory disorders within the United States. Its current pipeline includes tetrahydrocannabinol glycoside, identified as VBX-100, an orally administered cannabinoid prodrug engineered to combat inflammatory bowel disease (IBD)...
Where does VBIO trade?
Malachite Innovations, Inc. (VBIO) trades on the Other OTC.
What sector is VBIO in?
Malachite Innovations, Inc. (VBIO) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Malachite Innovations, Inc.?
Michael R. Cavanaugh CPA, is the chief executive officer of Malachite Innovations, Inc. (VBIO).
Where is Malachite Innovations, Inc. headquartered?
Malachite Innovations, Inc. is headquartered in United States.
Does VBIO pay a dividend?
Malachite Innovations, Inc. (VBIO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did VBIO go public?
Malachite Innovations, Inc. (VBIO) completed its initial public offering in 2008.